Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center Study

Overview of attention for article published in Frontiers in Psychiatry, February 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial

Article in Pulmonary Circulation (January 2024)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension

Article in Frontiers in Pharmacology (August 2023)

Societal costs associated with pulmonary arterial hypertension: A study utilizing linked national registries

Article in Pulmonary Circulation (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.